---

---

tags : Biotech    symbols : GSK   

save search

---

Travel vaccines market size to increase by USD 2.44 billion from 2021 to 2026: Bharat Biotech Ltd. and CSL Ltd. among key vendors - Technavio
Published: 2023-04-13 (Crawled : 00:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50 |

n/a

| -12.06% | O: 2.76% H: 0.0% C: -0.26%
CSLLY | $87.96 3.3% 45K |

n/a

| -13.34% | O: 0.44% H: 0.83% C: 0.51%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 8.89% | O: 0.54% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -18.15% | O: -1.1% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -8.11% | O: 0.0% H: 1.63% C: 1.63%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 5.01% | O: 0.85% H: 0.76% C: 0.76%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| 3.74% | O: 0.19% H: 0.93% C: 0.84%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -18.62% | O: 0.29% H: 0.0% C: 0.0%
AVDL | $17.4 -3.28% -3.39% 1.1M |

Health Technology

| 78.44% | O: 0.21% H: 6.44% C: 4.41%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -7.45% | O: 0.39% H: 1.05% C: 0.97%
biotech travel market

---

Global Active Pharmaceutical Ingredients (APIs) Market Report, 2022 & 2023-2027: Biotech APIs Used in Biologics are Increasingly Becoming the Top-Selling Drugs in the Market
Published: 2023-01-16 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| Email alert Add to watchlist
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| Email alert Add to watchlist
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| Email alert Add to watchlist
global active biotech market

---

Vaccines Market to grow at a CAGR of 4.13% by 2026, Evolving Opportunities with Johnson and Johnson & Bharat Biotech Ltd - Technavio
Published: 2022-08-05 (Crawled : 16:00) - prnewswire.com
MTLHY | $29.93 -11.69% 1.1K |

n/a

| 8.99% | O: -1.42% H: 0.0% C: -1.18%
CSLLY | $87.96 3.3% 45K |

n/a

| -14.34% | O: -2.96% H: 3.39% C: 2.91%
ALPMF | $9.594 43.47% 2.2K |

Health Technology

| -37.47% | O: -2.43% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -2.01% | O: -6.04% H: 2.59% C: 2.59%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -4.85% | O: 3.16% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 1.47% | O: 0.59% H: 0.0% C: -4.45%
ALPMY | $9.46 -1.11% 500K |

Manufacturing

| -37.51% | O: 0.03% H: 0.07% C: 0.07%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -2.46% | O: -1.26% H: 1.36% C: 1.2%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -7.82% | O: -0.32% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 2.98% | O: -0.63% H: 0.63% C: 0.24%
biotech market

---

$72.6 Billion Worldwide Biotech Ingredients Industry to 2027 - Featuring AbbVie Advanced Biotech and Amyris Among Others
Published: 2022-07-14 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -20.39% | O: -3.79% H: 2.41% C: 0.26%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -6.51% | O: -1.46% H: 0.09% C: 0.09%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -22.58% | O: -1.96% H: 0.35% C: 0.25%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 8.55% | O: -2.18% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -8.1% | O: -1.27% H: 0.0% C: 0.0%
BRKR | $78.56 -5.28% -5.58% 2.2M |

Health Technology

| 33.83% | O: -1.42% H: 0.14% C: -1.32%
biotech

---

Tetanus Toxoid Vaccine Market - 39% of Growth to Originate from North America| Evolving Opportunities with Actiza Pharmaceutical Pvt. Ltd. & Bharat Biotech Ltd. | Technavio
Published: 2022-05-17 (Crawled : 14:00) - prnewswire.com
GIKLY | $4.6 132.75% 4.5K |

Manufacturing

| -54.0% | O: 5.0% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -25.87% | O: -0.92% H: 0.0% C: 0.0%
ZTS | News | $153.11 1.05% 0.48% 4.8M |

Health Technology

| -8.52% | O: 1.31% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -9.63% | O: 1.71% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -12.51% | O: 1.5% H: 0.64% C: 0.19%
biotech vaccine growth market

---

Vaccines Market Potential to Grow by USD 28.28 billion | Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co. Ltd. Emerge as Dominant Players | Technavio
Published: 2022-05-02 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -11.92% | O: 0.08% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 2.25% | O: -1.7% H: 0.0% C: -0.06%
ALPMY | $9.46 -1.11% 500K |

Manufacturing

| -38.43% | O: -1.05% H: 0.2% C: -0.27%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -13.1% | O: -0.92% H: 0.29% C: -0.95%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -15.53% | O: -2.05% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 2.81% | O: -0.35% H: 0.0% C: 0.0%
pharma biotech potential market

---

Marker Therapeutics Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors
Published: 2021-12-09 (Crawled : 12:30) - biospace.com/
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -7.06% | O: 0.68% H: 0.08% C: -0.23%
A | $132.44 -1.57% -0.36% 1.9M |

Health Technology

| -11.57% | O: 1.16% H: 0.96% C: -1.21%
MRKR | $4.24 -1.62% -1.65% 13K |

Consumer Services

| 288.29% | O: 8.11% H: 2.5% C: -3.33%
therapeutics biotech iot

---

GSK and Vir Biotechnology Announce United States Government Agreements to Purchase Sotrovimab, a COVID-19 Treatment
Published: 2021-11-17 (Crawled : 12:00) - globenewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -2.23% | O: 1.43% H: 2.31% C: 2.27%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -6.54% | O: -0.28% H: 0.0% C: 0.0%
VIR | $7.96 -3.52% -3.64% 880K |

Health Technology

| -74.73% | O: 9.97% H: 4.0% C: -6.28%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -11.13% | O: -0.06% H: 0.0% C: 0.0%
covid treatment biotech technology iot covid-19

---

Celiac Diseases Drugs Market Report Featuring Major Vendors including Amgen Inc., AMYRA Biotech AG & BioLineRx Ltd. | Discover Company Insights in Technavio
Published: 2021-09-06 (Crawled : 08:00) - prnewswire.com
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| Email alert Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| Email alert Add to watchlist
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| Email alert Add to watchlist
BLRX | $0.6411 3.17% 3.07% 310K |

Health Technology

| Email alert Add to watchlist
disease biotech drug iot

---

GSK and Vir Biotechnology Announce Joint Procurement Agreement with European Commission for COVID-19 Treatment, Sotrovimab
Published: 2021-07-28 (Crawled : 12:00) - biospace.com/
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 0.2% | O: -1.06% H: 1.31% C: 1.02%
VIR | $7.96 -3.52% -3.64% 880K |

Health Technology

| -77.36% | O: 1.54% H: 4.68% C: 0.14%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -11.8% | O: -0.5% H: 1.7% C: 1.4%
covid treatment europe biotech technology iot covid-19

---

Global Nanobiotechnology Applications and Markets 2021-2026: Molecular Diagnostic, Therapeutics, & Biopharmaceutical Application
Published: 2021-07-27 (Crawled : 20:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -16.05% | O: 0.04% H: 0.38% C: -0.32%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 0.2% | O: -1.06% H: 1.31% C: 1.02%
AVDL | $17.4 -3.28% -3.39% 1.1M |

Health Technology

| 117.25% | O: -0.88% H: 1.89% C: -1.51%
biopharma molecular biotech technology iot application diagnostic

---

Biodefense Market Growth Analysis in Biotechnology Industry | Technavio
Published: 2021-07-08 (Crawled : 04:00) - prnewswire.com
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -1.59% | O: -0.89% H: 0.35% C: 0.23%
defense biotech growth technology iot market

---

GSK and Vir Biotechnology Announce Continuing Progress of the COMET Clinical Development Program for Sotrovimab
Published: 2021-06-21 (Crawled : 12:00) - biospace.com/
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -0.6% | O: -0.15% H: 0.33% C: 0.0%
VIR | $7.96 -3.52% -3.64% 880K |

Health Technology

| -82.12% | O: 0.5% H: 6.27% C: 5.89%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -13.9% | O: -0.32% H: 0.17% C: -0.13%
ev biotech technology iot

---

Global Travel Vaccines Market to witness $ 2.23 Bn growth during 2021-2025 | Bharat Biotech Ltd., CSL Ltd., and GlaxoSmithKline Plc to emerge as major players | Technavio
Published: 2021-06-11 (Crawled : 11:00) - prnewswire.com
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -1.57% | O: 0.05% H: 0.12% C: -0.25%
travel biotech vaccine growth iot merge

---

GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives Emergency Use Authorization from the US FDA for Treatment of Mild-to-Moderate COVID-19 in High-Risk Adults and Pediatric Patients
Published: 2021-05-26 (Crawled : 23:00) - globenewswire.com
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 2.3% | O: -0.8% H: 0.69% C: 0.23%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 273.54% | O: -0.17% H: 0.36% C: -0.72%
VIR | $7.96 -3.52% -3.64% 880K |

Health Technology

| -81.97% | O: 4.2% H: 0.3% C: -9.4%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -15.58% | O: -0.5% H: 0.32% C: -1.27%
covid treatment fda risk biotech technology iot merge authorized emergency use authorization

---

CORRECTION -- EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
Published: 2021-05-21 (Crawled : 14:00) - globenewswire.com
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 1.46% | O: -0.26% H: 0.26% C: -0.21%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 276.27% | O: 0.24% H: 0.96% C: -0.06%
VIR | $7.96 -3.52% -3.64% 880K |

Health Technology

| -81.73% | O: 1.75% H: 0.13% C: -1.44%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -15.78% | O: -0.43% H: 0.2% C: 0.02%
covid treatment positive biotech technology iot ema

---

EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
Published: 2021-05-21 (Crawled : 12:15) - globenewswire.com
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 1.46% | O: -0.26% H: 0.26% C: -0.21%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 276.27% | O: 0.24% H: 0.96% C: -0.06%
VIR | $7.96 -3.52% -3.64% 880K |

Health Technology

| -81.73% | O: 1.75% H: 0.13% C: -1.44%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -15.78% | O: -0.43% H: 0.2% C: 0.02%
covid treatment positive biotech technology iot ema

---

GSK and Vir Biotechnology Announce the Start of the EMA Rolling Review of VIR-7831 (sotrovimab) for the Early Treatment of COVID-19
Published: 2021-05-07 (Crawled : 14:00) - biospace.com/
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 4.46% | O: 0.5% H: 0.84% C: 0.66%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 287.21% | O: 0.48% H: 0.74% C: 0.31%
VIR | $7.96 -3.52% -3.64% 880K |

Health Technology

| -80.17% | O: 3.24% H: 2.94% C: 0.02%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -10.78% | O: 0.92% H: 0.88% C: 0.66%
covid treatment biotech technology iot ema

---

GSK and Vir Biotechnology Announce EMA Review of Dual-Action Monoclonal Antibody VIR-7831 for the Early Treatment of COVID-19
Published: 2021-04-15 (Crawled : 14:00) - globenewswire.com
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 9.6% | O: 4.23% H: 1.59% C: 0.08%
VIR | $7.96 -3.52% -3.64% 880K |

Health Technology

| -81.89% | O: 0.37% H: 2.8% C: -1.49%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -9.41% | O: 0.76% H: 0.61% C: 0.14%
covid treatment antibody biotech technology iot ema

---

Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with VIR-7831 in Low-Risk Adults with COVID-19
Published: 2021-03-29 (Crawled : 14:00) - biospace.com/
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 7.99% | O: -0.82% H: 1.18% C: 0.88%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 305.14% | O: -0.35% H: 1.63% C: 0.91%
VIR | $7.96 -3.52% -3.64% 880K |

Health Technology

| -83.99% | O: -1.46% H: 1.02% C: -4.73%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -8.3% | O: -0.56% H: 0.83% C: 0.57%
covid phase 2 risk positive topline biotech technology iot trial

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | News | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | News | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---